Laurel Wealth Advisors LLC Abb Vie Inc. Transaction History

Laurel Wealth Advisors LLC

$617 Million
Q3 2024

A detailed history of Laurel Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 31,737 shares of ABBV stock, worth $5.66 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

31,737

Previous 32,187 1.4%

Holding current value

$5.66 Million

Previous $5.52 Million 13.53%

% of portfolio

1.02%

Previous 0.88%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $73,728 - $89,698	-450 Reduced 1.4%	31,737 $6.27 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $148,443 - $173,348	-959 Reduced 2.89%	32,187 $5.52 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $21,415 - $24,401	-134 Reduced 0.4%	33,146 $6.04 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $8,806 - $9,918	-64 Reduced 0.19%	33,280 $5.16 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $281,073 - $325,383	-2,104 Reduced 5.94%	33,344 $4.97 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $157,024 - $195,406	-1,185 Reduced 3.23%	35,448 $4.78 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $94,430 - $108,750	653 Added 1.81%	36,633 $5.84 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $385,608 - $462,445	2,788 Added 8.4%	35,980 $5.82 Million
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $328,009 - $376,204	2,444 Added 7.95%	33,192 $4.46 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $105,279 - $133,844	765 Added 2.55%	30,748 $4.71 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $48,304 - $59,932	-366 Reduced 1.21%	29,983 $4.86 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $133,750 - $169,232	1,245 Added 4.28%	30,349 $4.11 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $140,235 - $159,188	-1,318 Reduced 4.33%	29,104 $3.14 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $238,405 - $265,597	2,266 Added 8.05%	30,422 $3.43 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $273,141 - $300,695	2,670 Added 10.48%	28,156 $3.05 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $285,337 - $385,235	3,545 Added 16.16%	25,486 $2.73 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $370,443 - $434,778	4,312 Added 24.46%	21,941 $1.92 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $501,410 - $670,962	6,834 Added 63.31%	17,629 $1.73 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $75,787 - $114,903	1,175 Added 12.21%	10,795 $822,000
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $14,065 - $17,598	-195 Reduced 1.99%	9,620 $852,000
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $41,566 - $49,975	-660 Reduced 6.3%	9,815 $743,000
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $4,073 - $5,206	-62 Reduced 0.59%	10,475 $762,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $27,770 - $32,684	-360 Reduced 3.3%	10,537 $849,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $848,331 - $1.05 Million	10,897 New	10,897 $1.01 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors LLC with notifications on news.

Account

Laurel Wealth Advisors LLC Abb Vie Inc. Transaction History